Fluoroscopy-guided suprascapular and subscapular articular nerve blocks for chronic shoulder pain: A 12-week observational study

Anuj Jain , Jithin K.J. , Harish Kumar , Radha Sarawagi , Ashutosh Kaushal , Swapnil Kumar Barasker
{"title":"Fluoroscopy-guided suprascapular and subscapular articular nerve blocks for chronic shoulder pain: A 12-week observational study","authors":"Anuj Jain ,&nbsp;Jithin K.J. ,&nbsp;Harish Kumar ,&nbsp;Radha Sarawagi ,&nbsp;Ashutosh Kaushal ,&nbsp;Swapnil Kumar Barasker","doi":"10.1016/j.inpm.2025.100582","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Chronic shoulder pain is a common musculoskeletal complaint. This study evaluates the effectiveness of fluoroscopy-guided suprascapular (SSN) and subscapular (SCN) articular branch blocks in managing chronic shoulder pain. The primary objective was to assess pain relief using a numerical rating scale (NRS) and functional improvement using Shoulder Pain and Disability Index (SPADI) over 12 weeks.</div></div><div><h3>Methods</h3><div>This prospective, single-arm observational study included 70 adults with chronic shoulder pain (≥3 months) meeting predefined criteria. All patients underwent fluoroscopy-guided SSN and SCN articular branch blocks with bupivacaine (2 ml, 0.5 %) and triamcinolone (0.5 ml, 20 mg) per site. NRS and SPADI were recorded at baseline and biweekly for 12 weeks. Secondary outcomes included range of motion (ROM) improvements and night pain resolution. Statistical analysis involved repeated measures ANOVA for normally distributed data and non-parametric tests for skewed data (p &lt; 0.05 considered significant).</div></div><div><h3>Results</h3><div>At 12 weeks, 78 % of patients achieved ≥50 % pain reduction. Mean NRS decreased from 7.6 ± 1.1 to 3.9 ± 1.1, while SPADI pain and disability scores improved by 57.1 % and 57.4 %, respectively (p &lt; 0.001). Night pain resolved in all affected patients within two weeks. Repeated measures ANOVA confirmed significant improvements in pain and disability scores (p &lt; 0.001). Mean lateral abduction improved by 29° (95 % CI: 22.8°–35.2°, p &lt; 0.001).</div></div><div><h3>Conclusion</h3><div>Fluoroscopy-guided SSN and SCN articular branch blocks provide significant pain relief and functional improvement in chronic shoulder pain, offering a potential alternative to intra-articular injections or surgery in select patients.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"4 2","pages":"Article 100582"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interventional Pain Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772594425000433","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Chronic shoulder pain is a common musculoskeletal complaint. This study evaluates the effectiveness of fluoroscopy-guided suprascapular (SSN) and subscapular (SCN) articular branch blocks in managing chronic shoulder pain. The primary objective was to assess pain relief using a numerical rating scale (NRS) and functional improvement using Shoulder Pain and Disability Index (SPADI) over 12 weeks.

Methods

This prospective, single-arm observational study included 70 adults with chronic shoulder pain (≥3 months) meeting predefined criteria. All patients underwent fluoroscopy-guided SSN and SCN articular branch blocks with bupivacaine (2 ml, 0.5 %) and triamcinolone (0.5 ml, 20 mg) per site. NRS and SPADI were recorded at baseline and biweekly for 12 weeks. Secondary outcomes included range of motion (ROM) improvements and night pain resolution. Statistical analysis involved repeated measures ANOVA for normally distributed data and non-parametric tests for skewed data (p < 0.05 considered significant).

Results

At 12 weeks, 78 % of patients achieved ≥50 % pain reduction. Mean NRS decreased from 7.6 ± 1.1 to 3.9 ± 1.1, while SPADI pain and disability scores improved by 57.1 % and 57.4 %, respectively (p < 0.001). Night pain resolved in all affected patients within two weeks. Repeated measures ANOVA confirmed significant improvements in pain and disability scores (p < 0.001). Mean lateral abduction improved by 29° (95 % CI: 22.8°–35.2°, p < 0.001).

Conclusion

Fluoroscopy-guided SSN and SCN articular branch blocks provide significant pain relief and functional improvement in chronic shoulder pain, offering a potential alternative to intra-articular injections or surgery in select patients.
透视引导下肩胛上和肩胛下关节神经阻滞治疗慢性肩关节疼痛:一项为期12周的观察性研究
慢性肩痛是一种常见的肌肉骨骼疾病。本研究评估了透视引导下肩胛上(SSN)和肩胛下(SCN)关节分支阻滞治疗慢性肩关节疼痛的有效性。主要目的是在12周内使用数值评定量表(NRS)评估疼痛缓解,使用肩痛和残疾指数(SPADI)评估功能改善。方法:这项前瞻性单臂观察性研究纳入了70例符合预定标准的慢性肩痛(≥3个月)患者。所有患者均接受了透视引导下的SSN和SCN关节支阻滞,每个部位使用布比卡因(2ml, 0.5%)和曲安奈德酮(0.5 ml, 20mg)。NRS和SPADI在基线和每两周记录一次,持续12周。次要结果包括活动范围(ROM)改善和夜间疼痛缓解。统计分析包括对正态分布数据的重复测量方差分析和对偏态数据的非参数检验(p <;0.05认为显著)。结果12周后,78%的患者疼痛减轻≥50%。平均NRS从7.6±1.1降至3.9±1.1,SPADI疼痛和残疾评分分别提高57.1%和57.4% (p <;0.001)。所有患者的夜间疼痛均在两周内消失。重复测量方差分析证实疼痛和残疾评分有显著改善(p <;0.001)。平均外侧外展改善29°(95% CI: 22.8°-35.2°,p <;0.001)。结论透视引导下的SSN和SCN关节分支阻滞可显著缓解慢性肩关节疼痛并改善功能,为特定患者提供了关节内注射或手术的潜在替代方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信